NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

HPRA interrupts supply of fake Covid-19 tests

By Mindo - 18th Jun 2021

Man looking at COVID-19 rapid test result. Self - sampling. IgG.

Potentially counterfeit Covid-19 tests have been offered for sale to Irish individuals and businesses, the Health Products Regulatory Authority (HPRA) has confirmed. A spokesperson for the Authority said a “small number” of such instances had occurred to date, but that the supply was successfully “interrupted” through the cooperation of would-be purchasers.

“The HPRA is aware of a small number of instances where potentially falsified Covid-19 tests have been offered to individuals/entities in Ireland and with their cooperation this supply has been interrupted,” said the spokesperson.
“Should the public have concerns in relation to potentially falsified tests available in Ireland, they are encouraged to report the issue to the HPRA via email at or”

The HPRA monitors medical devices placed on the Irish market and conducts inspections at medical device manufacturing facilities. It also monitors the market for potentially falsified medical devices, including in-vitro diagnostic tests related to Covid-19. Last year, the HPRA detained 1.6 million units of illegal medicines, an increase of 58 per cent on 2019.

Among these were more than 56,000 units of Covid-19 medicines, the majority of which related to traditional Chinese medicine not approved or authorised for use in Ireland. Meanwhile, the Authority said the supply of medicines has not been “significantly” affected by Brexit and is unlikely to be in the future based on comparisons of drug shortage data for 2020 and 2021.

“This is reflected in the number of medicines shortages that have been notified to the HPRA in the first five months of 2021, which is fully consistent with previous years,” said the spokesperson.

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read